TCT-49 A Comparison of 5 mg Prasugrel With 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity
Joseph A. Jakubowski(Indiana Biosciences Research Institute), Dominick J. Angiolillo(University of Florida), Tomas Lindahl(Linköping University), Stefan James(Uppsala University), Jurriën M. ten Berg(St. Antonius Ziekenhuis), Patricia Brown(Eli Lilly (United States)), Chunmei Zhou(Eli Lilly (United States)), Kenneth J. Winters(Eli Lilly (United States)), Peter J Svensson(Malmö University), David Erlinge(Lund University), Paul A. Gurbel(Sinai Hospital)
Cited by 0
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k